66 related articles for article (PubMed ID: 16055145)
1. In vitro modification of solid phase multiple antigenic peptides/autoantigens with 4-hydroxy-2-nonenal (HNE) provide ideal substrates for detection of anti-HNE antibodies and peptide antioxidants.
Kurien BT; Scofield RH
J Immunol Methods; 2005 Aug; 303(1-2):66-75. PubMed ID: 16055145
[TBL] [Abstract][Full Text] [Related]
2. Putative sequences on Ro60 three-dimensional structure accessible for 4-hydroxy-2-nonenal (HNE) modification compared to in vitro HNE modification of Ro60 sequences.
Kurien BT; D'Souza A; Terzyan S; Scofield RH
Mol Immunol; 2012 Apr; 50(4):185-92. PubMed ID: 22336572
[TBL] [Abstract][Full Text] [Related]
3. Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading.
Scofield RH; Kurien BT; Ganick S; McClain MT; Pye Q; James JA; Schneider RI; Broyles RH; Bachmann M; Hensley K
Free Radic Biol Med; 2005 Mar; 38(6):719-28. PubMed ID: 15721982
[TBL] [Abstract][Full Text] [Related]
4. Induction of anti-Ro60/anti-La by immunisation with spectrin and induction of anti-spectrin by immunisation with Ro60 and 4-hydroxy-2-nonenal-modified Ro60 immunisation.
Kurien BT; Dorri Y; Bachmann M; Scofield RH
Clin Exp Rheumatol; 2012; 30(6):886-93. PubMed ID: 22776429
[TBL] [Abstract][Full Text] [Related]
5. Curcumin/turmeric solubilized in sodium hydroxide inhibits HNE protein modification--an in vitro study.
Kurien BT; Scofield RH
J Ethnopharmacol; 2007 Mar; 110(2):368-73. PubMed ID: 17116380
[TBL] [Abstract][Full Text] [Related]
6. Protein-bound 4-hydroxy-2-nonenal: an endogenous triggering antigen of antI-DNA response.
Toyoda K; Nagae R; Akagawa M; Ishino K; Shibata T; Ito S; Shibata N; Yamamoto T; Kobayashi M; Takasaki Y; Matsuda T; Uchida K
J Biol Chem; 2007 Aug; 282(35):25769-78. PubMed ID: 17588942
[TBL] [Abstract][Full Text] [Related]
7. Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies.
Uchida K; Itakura K; Kawakishi S; Hiai H; Toyokuni S; Stadtman ER
Arch Biochem Biophys; 1995 Dec; 324(2):241-8. PubMed ID: 8554315
[TBL] [Abstract][Full Text] [Related]
8. The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct.
Toyokuni S; Miyake N; Hiai H; Hagiwara M; Kawakishi S; Osawa T; Uchida K
FEBS Lett; 1995 Feb; 359(2-3):189-91. PubMed ID: 7867796
[TBL] [Abstract][Full Text] [Related]
9. Degree of modification of Ro60 by the lipid peroxidation by-product 4-hydroxy-2-nonenal may differentially induce Sjögren syndrome or systemic lupus erythematosus in BALB/c mice.
Kurien BT; Porter A; Dorri Y; Iqbal S; D'Souza A; Singh A; Asfa S; Cartellieri M; Mathias K; Matsumoto H; Bachmann M; Hensley K; Scofield RH
Free Radic Biol Med; 2011 May; 50(10):1222-33. PubMed ID: 20946951
[TBL] [Abstract][Full Text] [Related]
10. Quantitative radioligand assays using de novo-synthesized recombinant autoantigens in connective tissue diseases: new tools to approach the pathogenic significance of anti-RNP antibodies in rheumatic diseases.
Yamamoto AM; Amoura Z; Johannet C; Jeronimo AL; Campos H; Koutouzov S; Piette JC; Bach JF
Arthritis Rheum; 2000 Mar; 43(3):689-98. PubMed ID: 10728764
[TBL] [Abstract][Full Text] [Related]
11. Linear epitope mapping of an Sm B/B' polypeptide.
James JA; Harley JB
J Immunol; 1992 Apr; 148(7):2074-9. PubMed ID: 1372022
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of actin to modification by 4-hydroxy-2-nonenal.
Ozeki M; Miyagawa-Hayashino A; Akatsuka S; Shirase T; Lee WH; Uchida K; Toyokuni S
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Nov; 827(1):119-26. PubMed ID: 15886073
[TBL] [Abstract][Full Text] [Related]
13. Induction of autoimmunity by multivalent immunodominant and subdominant T cell determinants of La (SS-B).
Farris AD; Brown L; Reynolds P; Harley JB; James JA; Scofield RH; McCluskey J; Gordon TP
J Immunol; 1999 Mar; 162(5):3079-87. PubMed ID: 10072561
[TBL] [Abstract][Full Text] [Related]
14. Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxynonenal- and malondialdehyde-protein adducts.
Hartley DP; Kroll DJ; Petersen DR
Chem Res Toxicol; 1997 Aug; 10(8):895-905. PubMed ID: 9282839
[TBL] [Abstract][Full Text] [Related]
15. A model of peptide-induced lupus autoimmune B cell epitope spreading is strain specific and is not H-2 restricted in mice.
James JA; Harley JB
J Immunol; 1998 Jan; 160(1):502-8. PubMed ID: 9552009
[TBL] [Abstract][Full Text] [Related]
16. Immunologic and structural studies of the lupus/Sjögren's syndrome autoantigen, La/SSB, with a monoclonal antibody.
Harley JB; Rosario MO; Yamagata H; Fox OF; Koren E
J Clin Invest; 1985 Aug; 76(2):801-6. PubMed ID: 2411763
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of enzyme inactivation by an endogenous electrophile 4-hydroxy-2-nonenal: identification of modification sites in glyceraldehyde-3-phosphate dehydrogenase.
Ishii T; Tatsuda E; Kumazawa S; Nakayama T; Uchida K
Biochemistry; 2003 Apr; 42(12):3474-80. PubMed ID: 12653551
[TBL] [Abstract][Full Text] [Related]
18. Oxidatively modified autoantigens in autoimmune diseases.
Kurien BT; Hensley K; Bachmann M; Scofield RH
Free Radic Biol Med; 2006 Aug; 41(4):549-56. PubMed ID: 16863987
[TBL] [Abstract][Full Text] [Related]
19. Immunization with a peptide of Sm B/B' results in limited epitope spreading but not autoimmune disease.
Mason LJ; Timothy LM; Isenberg DA; Kalsi JK
J Immunol; 1999 May; 162(9):5099-105. PubMed ID: 10227979
[TBL] [Abstract][Full Text] [Related]
20. Modification of heat shock protein 90 by 4-hydroxynonenal in a rat model of chronic alcoholic liver disease.
Carbone DL; Doorn JA; Kiebler Z; Ickes BR; Petersen DR
J Pharmacol Exp Ther; 2005 Oct; 315(1):8-15. PubMed ID: 15951401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
